Stay updated on Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page.

Latest updates to the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now displays Revision: v3.6.3 instead of Revision: v3.6.2, signaling a minor revision to the page's underlying template or content. This update does not alter the study information or user-facing content.SummaryDifference0.0%

- Check16 days agoChange DetectedA new Revision: v3.6.2 tag was added, replacing the previous v3.6.0. This appears to be a minor backend/documentation update without affecting the study details shown on the page.SummaryDifference0.0%

- Check30 days agoChange DetectedThe study page now shows a recruitment status note 'No longer looking for participants' and adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment label formatting (from 'Intervention / Treatment' to 'Intervention/Treatment') and records the site revision as v3.6.0.SummaryDifference0.3%

- Check37 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a maintenance update to the page’s underlying system. The change does not appear to modify the visible study content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the study record's metadata rather than substantive content changes.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page now shows Revision: v3.5.3, replacing the previous v3.5.2 revision, indicating a new edition of the page.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chinese Adults with Atopic Dermatitis Clinical Trial page.